Entrada Therapeutics, Inc.

TRDA

$7.11

-0.84%

2026-09-04 09:50:19 EDT-$0.06

Healthcare

Biotechnology

NASDAQ

Active Trading

Entrada Therapeutics, Inc. operates as a biotechnology enterprise dedicated to pioneering endosomal escape vehicle (EEV) therapeutics, specifically engineered to tackle a range ...

Historical Employee Count of TRDA

Current

152

Change

-16.94%

Minimum

114

Maximum

183

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Dec 31, 2025	152	10-K	Feb 26, 2026	View
Dec 31, 2024	183	10-K	Feb 27, 2025	View
Dec 31, 2023	159	10-K	Mar 13, 2024	View
Dec 31, 2022	130	10-K	Mar 6, 2023	View
Dec 31, 2021	114	10-K	Mar 15, 2022	View

Supply Chain of TRDA

Upstream / Downstream / Proxies

Upstream

Vertex Pharmaceuticals IncorporatedNASDAQ:VRTX Thermo Fisher Scientific Inc. (Patheon Pharma Services)NYSE:TMO Catalent, Inc.NYSE:CTLT WuXi AppTec Co., Ltd.HKEx:2359 Charles River Laboratories International, Inc.NYSE:CRL Fortrea Holdings Inc.NASDAQ:FTREVelocity Clinical Research, Inc.Azenta Life Sciences (formerly Brooks Life Sciences)NASDAQ:AZTACordenPharma InternationalBachem Holding AGSWX:BANBTwist Bioscience CorporationNASDAQ:TWST Agilent Technologies, Inc.NYSE:A

Downstream

Vertex Pharmaceuticals IncorporatedNASDAQ:VRTXPatients with Duchenne Muscular Dystrophy (DMD)Patients with Usher Syndrome Type 2A (USH2A) / Inherited Retinal DiseasesPatients with Myotonic Dystrophy Type 1 (DM1)

Proxies

Dyne Therapeutics, Inc.NASDAQ:DYN PepGen Inc.NASDAQ:PEPG Sarepta Therapeutics, Inc.NASDAQ:SRPT Wave Life Sciences Ltd.NASDAQ:WVE

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer